Thiard News@F4F

@newsen.bsky.social

1 week ago

GC Biopharma Secures Major Approval for Varicella Vaccine Launch in Guatemala GC Biopharma has received marketing authorization for its varicella vaccine, BARYCELA, in Guatemala, marking a crucial step in expanding access to vaccinations in Latin America.

GC Biopharma Secures Major Approval for Varicella Vaccine Launch in Guatemala #GC_Biopharma #Guatemala #vaccines #Guatemala_City #BARYCELA

Thiard News@F4F

@newsen.bsky.social

3 weeks ago

GC Biopharma's Comprehensive Review on 30 Years of MAV/06 Varicella Vaccine Research GC Biopharma has published a detailed review showcasing 30 years of research on its MAV/06 varicella vaccine, highlighting its safety and efficacy across multiple strains.

GC Biopharma's Comprehensive Review on 30 Years of MAV/06 Varicella Vaccine Research #South_Korea #GC_Biopharma #Yongin #Varicella_Vaccine #MAV/06

Thiard News@F4F

@newsen.bsky.social

3 months ago

GC Biopharma Achieves Approval for COVID-19 mRNA Vaccine Trial in Korea GC Biopharma has secured IND approval for its COVID-19 mRNA vaccine, marking a significant milestone in vaccine development in South Korea.

GC Biopharma Achieves Approval for COVID-19 mRNA Vaccine Trial in Korea #South_Korea #GC_Biopharma #Yongin #COVID-19 #mRNA_Vaccine

Thiard News@F4F

@newsen.bsky.social

3 months ago

GC Biopharma Successfully Launches the World’s First Recombinant Anthrax Vaccine: BARYTHRAX inj. GC Biopharma announces the shipment of BARYTHRAX inj., the world's first recombinant anthrax vaccine, enhancing public health defense globally.

GC Biopharma Successfully Launches the World’s First Recombinant Anthrax Vaccine: BARYTHRAX inj. #South_Korea #GC_Biopharma #Yongin #Anthrax_Vaccine #BARYTHRAX_inj.

Thiard News@F4F

@newsen.bsky.social

4 months ago

GC Biopharma's MAV/06 Vaccine Strain Gains WHO Recognition for Varicella Vaccination GC Biopharma's proprietary varicella vaccine strain, MAV/06, has received official recognition from the WHO, enhancing global vaccination efforts and supply security.

GC Biopharma's MAV/06 Vaccine Strain Gains WHO Recognition for Varicella Vaccination #South_Korea #GC_Biopharma #Yongin #Varicella_Vaccine #MAV/06

Thiard News@F4F

@newsen.bsky.social

4 months ago

GC Biopharma Enhances Ig Therapy Through Education and Patient Insight at 2025 IgNS Meeting GC Biopharma is advancing Ig therapy standards at the 2025 IgNS Annual Meeting, focusing on education, patient safety, and positive outcomes.

GC Biopharma Enhances Ig Therapy Through Education and Patient Insight at 2025 IgNS Meeting #USA #GC_Biopharma #Teaneck #ALYGLO #IgNS

Thiard News@F4F

@newsen.bsky.social

5 months ago

GC Biopharma's Breakthrough Anthrax Vaccine BARYTHRAX Shows Promising Safety and Efficacy GC Biopharma announces successful Phase 2 data for BARYTHRAX, the world's first recombinant anthrax vaccine, showcasing safety and strong immune response.

GC Biopharma's Breakthrough Anthrax Vaccine BARYTHRAX Shows Promising Safety and Efficacy #South_Korea #GC_Biopharma #Yongin #BARYTHRAX #Anthrax_Vaccine

Thiard News@F4F

@newsen.bsky.social

5 months ago

GC Biopharma to Host Symposium on Primary Immunodeficiency and IVIG Innovations at IgNS Annual Meeting 2025 GC Biopharma will present a symposium focused on patient experiences and IVIG advancements at the upcoming 2025 IgNS Annual Meeting in Dallas.

GC Biopharma to Host Symposium on Primary Immunodeficiency and IVIG Innovations at IgNS Annual Meeting 2025 #USA #Dallas #GC_Biopharma #IVIG #ALYGLO

Thiard News@F4F

@newsen.bsky.social

5 months ago

GC Biopharma Shines at 2025 CIIC Conference: Focus on IVIG Innovation GC Biopharma USA, a leader in plasma-derived products, showcased IVIG innovation and its IIR Program at the CIIC Fall Conference in Tampa, emphasizing collaboration in patient care.

GC Biopharma Shines at 2025 CIIC Conference: Focus on IVIG Innovation #USA #GC_Biopharma #Tampa #ALYGLO #IIR_Program

Thiard News@F4F

@newsen.bsky.social

5 months ago

GC Biopharma Expands Presence in Global Shingles Vaccine Market GC Biopharma secures CMO rights for a new shingles vaccine amid a competitive market, presenting a potential alternative to GSK's Shingrix.

GC Biopharma Expands Presence in Global Shingles Vaccine Market #South_Korea #GC_Biopharma #Yongin #Curevo_Vaccine #Shingles_Vaccine

Thiard News@F4F

@newsen.bsky.social

6 months ago

GC Biopharma Moves Ahead with Phase 1 Trial for COVID-19 mRNA Vaccine GC Biopharma has submitted an IND application for its COVID-19 mRNA vaccine, GC4006A, aiming to begin Phase 1 trials in early 2026.

GC Biopharma Moves Ahead with Phase 1 Trial for COVID-19 mRNA Vaccine #GC_Biopharma #Yongin #COVID-19 #mRNA_Vaccine

Thiard News@F4F

@newsen.bsky.social

7 months ago

GC Biopharma Initiates Phase 3 Clinical Trial for BARYCELA Vaccine in Thailand GC Biopharma has submitted an IND for a Phase 3 trial of BARYCELA, a varicella vaccine, aiming for approval in Southeast Asia by 2027.

GC Biopharma Initiates Phase 3 Clinical Trial for BARYCELA Vaccine in Thailand #South_Korea #GC_Biopharma #Yongin #Phase_3_Trial #BARYCELA

Thiard News@F4F

@newsen.bsky.social

7 months ago

GC Biopharma Unveils Mechanism Behind Hunterase Delivery in Groundbreaking Study GC Biopharma's latest research reveals how Hunterase effectively delivers treatment for Hunter syndrome by targeting lysosomes, enhancing therapy efficacy.

GC Biopharma Unveils Mechanism Behind Hunterase Delivery in Groundbreaking Study #South_Korea #GC_Biopharma #Yongin #Hunterase #Idursulfase_beta

Thiard News@F4F

@newsen.bsky.social

7 months ago

GC Biopharma and Thai Red Cross Unite for Innovative Plasma Therapy Collaboration GC Biopharma strengthens its collaboration with Thai Red Cross Society through a new MOU to enhance local production of plasma-derived therapies.

GC Biopharma and Thai Red Cross Unite for Innovative Plasma Therapy Collaboration #South_Korea #GC_Biopharma #Yongin #Thai_Red_Cross #plasma_therapy

Thiard News@F4F

@newsen.bsky.social

7 months ago

GC Biopharma's ALYGLO Study Shows 14-Day Stability Under Refrigerated Storage GC Biopharma announces the publication of a study highlighting the robustness of ALYGLO, showing 14-day stability under refrigeration, enhancing patient care in immunotherapy.

GC Biopharma's ALYGLO Study Shows 14-Day Stability Under Refrigerated Storage #USA #GC_Biopharma #Teaneck #IVIG #ALYGLO

Thiard News@F4F

@newsen.bsky.social

8 months ago

GC Biopharma's BARYCELA Vaccine Awarded Marketing Authorization in Vietnam GC Biopharma's varicella vaccine BARYCELA has secured marketing authorization in Vietnam, a key step in its Southeast Asian expansion strategy.

GC Biopharma's BARYCELA Vaccine Awarded Marketing Authorization in Vietnam #Vietnam #GC_Biopharma #Yongin #BARYCELA #Varicella_Vaccine

Thiard News@F4F

@newsen.bsky.social

8 months ago

GC Biopharma Unveils Crucial IVIG Viscosity Research at ISTH 2025 Conference At the ISTH 2025 Congress, GC Biopharma revealed new insights into the viscosity of IVIG products, highlighting safety implications for patients at risk.

GC Biopharma Unveils Crucial IVIG Viscosity Research at ISTH 2025 Conference #USA #GC_Biopharma #Teaneck #ALYGLO #IVIG_Products

Thiard News@F4F

@newsen.bsky.social

9 months ago

GC Biopharma USA Showcases Innovative IVIG Manufacturing Techniques for Enhanced Patient Safety GC Biopharma USA presents a groundbreaking manufacturing process at the 2025 CIS Annual Meeting, focusing on IVIG safety and minimizing thromboembolic risks.

GC Biopharma USA Showcases Innovative IVIG Manufacturing Techniques for Enhanced Patient Safety #USA #GC_Biopharma #Teaneck #IVIG #ALYGLO

Thiard News@F4F

@newsen.bsky.social

10 months ago

GC Biopharma's Hunterase Phase 3 Trial Shows Promising Results for Hunter Syndrome Patients GC Biopharma has reported significant Phase 3 clinical trial outcomes for Hunterase, an innovative treatment for Hunter Syndrome, published in a leading journal.

GC Biopharma's Hunterase Phase 3 Trial Shows Promising Results for Hunter Syndrome Patients #South_Korea #GC_Biopharma #Yongin #Hunterase #Hunter_Syndrome

Thiard News@F4F

@newsen.bsky.social

10 months ago

GC Biopharma Achieves FDA Milestone with New Plasma Collection Center in California GC Biopharma's U.S. subsidiary, ABO Holdings, secures FDA approval for a plasma collection center in Calexico, paving the way for expansion.

GC Biopharma Achieves FDA Milestone with New Plasma Collection Center in California #United_States #FDA_Approval #GC_Biopharma #ABO_Holdings #Calexico

Thiard News@F4F

@newsen.bsky.social

11 months ago

GC Biopharma Pioneers Anthrax Vaccine Approval, Sets New Safety Standards GC Biopharma's innovative anthrax vaccine, BARYTHRAX, gains approval in South Korea, marking a breakthrough in vaccine safety and efficacy.

GC Biopharma Pioneers Anthrax Vaccine Approval, Sets New Safety Standards #South_Korea #GC_Biopharma #Yongin #BARYTHRAX #Anthrax_Vaccine

Thiard News@F4F

@newsen.bsky.social

1 year ago

GC Biopharma Unveils Significant Advances on Rare Disease Treatments at WORLD Symposium 2025 GC Biopharma revealed promising research on therapies for rare lysosomal storage disorders during the 2025 WORLD Symposium in San Diego, showcasing vital advancements.

GC Biopharma Unveils Significant Advances on Rare Disease Treatments at WORLD Symposium 2025 #South_Korea #GC_Biopharma #Yongin #Rare_Diseases #lysosomal_storage_disorders

Thiard News@F4F

@newsen.bsky.social

1 year ago

GC Biopharma and Novel Pharma Launch Clinical Trial for Sanfilippo Syndrome Treatment GC Biopharma and Novel Pharma have initiated a crucial Phase I clinical trial for a promising treatment of MPS IIIA, starting with the first patient in the US.

GC Biopharma and Novel Pharma Launch Clinical Trial for Sanfilippo Syndrome Treatment #South_Korea #GC_Biopharma #Sanfilippo_Syndrome #Clinical_Trial #Yongin

Thiard News@F4F

@newsen.bsky.social

1 year ago

New Associate Director of Human Resources Appointed at GC Biopharma USA GC Biopharma USA has appointed Christina Iskandar as the Associate Director of Human Resources, reinforcing its leadership team for growth.

New Associate Director of Human Resources Appointed at GC Biopharma USA #USA #GC_Biopharma #Teaneck #Christina_Iskandar #HR_Leaders

Thiard News@F4F

@newsen.bsky.social

1 year ago

Sean Zam Takes the Helm as Head of Sales and Marketing for GC Biopharma USA GC Biopharma USA has appointed Sean Zam as Head of Sales and Marketing, bringing his extensive pharmaceutical experience. He aims to strengthen community relationships and enhance patient impact.

Sean Zam Takes the Helm as Head of Sales and Marketing for GC Biopharma USA #USA #GC_Biopharma #Sean_Zam #Sales_and_Marketing #Teaneck